Compounds > (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane
Page last updated: 2024-08-26

(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and ketamine

(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane has been researched along with ketamine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukumoto, D; Harada, N; Kakiuchi, T; Nishiyama, S; Ohba, H; Sato, K; Tsukada, H1
Harada, N; Kakiuchi, T; Nishiyama, S; Ohba, H; Sato, K; Tsukada, H1
Domino, EF; Harada, N; Kakiuchi, T; Nishiyama, S; Ohba, H; Tsukada, H; Yamamoto, S1

Other Studies

3 other study(ies) available for (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and ketamine

ArticleYear
Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
    Synapse (New York, N.Y.), 2000, Volume: 37, Issue:2

    Topics: Animals; Brain; Carbon Radioisotopes; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Extracellular Space; Ketamine; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Nerve Tissue Proteins; Osmolar Concentration; Raclopride; Tomography, Emission-Computed

2000
Ketamine alters the availability of striatal dopamine transporter as measured by [(11)C]beta-CFT and [(11)C]beta-CIT-FE in the monkey brain.
    Synapse (New York, N.Y.), 2001, Dec-15, Volume: 42, Issue:4

    Topics: Anesthetics, Dissociative; Animals; Carbon Radioisotopes; Cerebrovascular Circulation; Cocaine; Contrast Media; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Ketamine; Macaca mulatta; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nortropanes; Time Factors; Tomography, Emission-Computed

2001
Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013, Volume: 38, Issue:13

    Topics: Analgesics; Analysis of Variance; Animals; Benzylamines; Brain; Carbon Isotopes; Cocaine; Consciousness; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Ketamine; Macaca mulatta; Magnetic Resonance Imaging; Male; Microdialysis; Positron-Emission Tomography; Serotonin Plasma Membrane Transport Proteins

2013